Russia does not plan to ban drug imports from Western countries
Print
15 September 2014
ThePharmaLetter
The Russian government has no plans to impose a ban on the pharmaceutical imports from the European Union and the USA, as proposed by some local top-officials, as a response to the next package of sanctions against Russia, which was yesterday approved by the EU. According to Russian Prime Minister Dmitry Medvedev, such a measure is currently considered as destructive.
However, despite the fact that the country’s government currently has no plans for imposition of a ban on drug imports to Russia, there are plans to create conditions for the establishment of production of some imported drugs within the country during the next several years.
At the same time, Russia’s current dependence on drug imports remains very high and the majority of the country’s analysts do not believe that the local pharmaceutical industry will be able to replace drug imports even in the long-term.
Share of local drugs just 23% by value
At present the share of local drugs is estimated at only 23% in value terms and 56% by volume. At the same time, according to ambitious plans of Russian President Vladimir Putin, by 2018 the share of domestic drugs in the overall structure of the market should reach 90%.
Last month, Russia “blacklisted” food imports including meat, poultry, fish, seafood, milk, dairy products, as well as fruits and vegetables from the EU, the USA, Australia, Canada and Norway.
At the same time, Russia’s current dependence on drug imports remains very high and the majority of the country’s analysts do not believe that the local pharmaceutical industry will be able to replace drug imports even in the long-term.
Share of local drugs just 23% by value
At present the share of local drugs is estimated at only 23% in value terms and 56% by volume. At the same time, according to ambitious plans of Russian President Vladimir Putin, by 2018 the share of domestic drugs in the overall structure of the market should reach 90%.
Last month, Russia “blacklisted” food imports including meat, poultry, fish, seafood, milk, dairy products, as well as fruits and vegetables from the EU, the USA, Australia, Canada and Norway.
All Portfolio
MEDIA CENTER
-
The RMI group has completed sertain projects
The RMI Group has exited from the capital of portfolio companies:
Marinus Pharmaceuticals, Inc.,
Syndax Pharmaceuticals, Inc.,
Atea Pharmaceuticals, Inc.